Peroxisome proliferator-activated receptor plays an important role in the expression of monocyte chemoattractant protein-1 and neointimal hyperplasia after vascular injury

7Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Peroxisome proliferator-activated receptor α is a member of the nuclear receptor superfamily. It modulates smooth muscle cell proliferation and inflammatory cytokines in vitro. In this study, we tested the hypothesis that PPAR would decrease the expression of monocyte chemoattractant protein-1 and tissue factor, and inhibit neointimal formation in a murine double carotid artery injury model. Carotid artery injury was performed in the PPAR knockout and wild type (WT) mice, treated and untreated with Wy14643, a PPAR activator. Up-regulated MCP-1 and TF expression and more neointimal formation were observed in the PPARα -/- mice compared with WT mice. The activation of PPAR resulted in further decreased neointimal formation. Our data further suggest that the decrease in neointimal formation is due to down-regulation of MCP-1 by PPAR resulting in decreased leukocyte infiltration and TF expression. Copyright © 2012 Yu Peng et al.

Cite

CITATION STYLE

APA

Peng, Y., Li, Q., Zhang, L., Bai, M., & Zhang, Z. (2012). Peroxisome proliferator-activated receptor plays an important role in the expression of monocyte chemoattractant protein-1 and neointimal hyperplasia after vascular injury. PPAR Research. https://doi.org/10.1155/2012/970525

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free